Our Goals
- Provide education, resources, and support to kidney cancer patients and caregivers
- Identify patients’ and researchers’ unmet needs
- Engage and educate policymakers on the urgency of kidney cancer research funding
- Urge Congress to fund kidney cancer research
- Increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
- Provide direct funding to promising ideas
- Propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
- Grow the community of kidney cancer researchers
- Support the development of new treatments by educating patients on trial access and enrollment
- Identify new unmet needs, set new goals, and keep working
Our Mission
Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.
NEWLY DIAGNOSED?
You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.
BUILD A CARE TEAM
Join Our Grassroots Army
What are we advocating for?
Awareness? Funding? Research? Cures?
Collaboration in action! 🤝
The KidneyCAN team was privileged to join forces with Merck's U.S. Patient Advocacy team and the International Kidney Cancer Coalition at Merck's Global Patient Day. Together, we're united in our mission to make a difference in the lives of ...#kidneycancer patients worldwide.
#KidneyCancerAdvocacy #GlobalPatientDay #AcceleratingCures 🧡🌍💚
Thank you @SenatorTester from Duane and Debbie Talcott and Granddaughter Scarlett for your support for cancer research funding and continuing telehealth. @kidneycan
Watch as @AdamPhilipStern and @DrChoueiri delve into the highlights of the #KCRS23 meeting and explain why this event stands out as their favorite in the kidney cancer community.
https://youtu.be/h63_6JONPDI
🎥 NEW VIDEO ALERT! Dive into the highlights of the KCRS23 meeting with Dr. Adam Stern, a #kidneycancer warrior, and Dr. Toni Choueiri from Dana-Farber, a leading voice in kidney cancer research. Discover why KCRS23 is a pivotal event in the kidney cancer community.
For an in-depth look ...at all the groundbreaking presentations, slides, and videos from KCRS23, visit: https://kcrs.kidneycan.org/kcrs23-presentations-video-slides/
Stay informed and be a part of the change in kidney cancer research!
#KCRS23 #KidneyCancerResearch
Thank you to Senator Jon Tester for meeting with the KidneyCAN delegation for #AdvocacyDays this week. Senator Tester supports robust funding for #kidneycancer research and champions access to telehealth.
🎥 NEW VIDEO ALERT! Dive into the highlights of the KCRS23 meeting with Dr. Adam Stern, a #kidneycancer warrior, and Dr. Toni Choueiri from Dana-Farber, a leading voice in kidney cancer research. Discover why KCRS23 is a pivotal event in the kidney cancer community.
For an in-depth look ...at all the groundbreaking presentations, slides, and videos from KCRS23, visit: https://kcrs.kidneycan.org/kcrs23-presentations-video-slides/
Stay informed and be a part of the change in kidney cancer research!
#KCRS23 #KidneyCancerResearch
https://youtu.be/h63_6JONPDI
NOTE: Watch all KCRS23 presentations and view slides at https://kcrs.kidneycan.org/kcrs23-presentations-video-slides/Join Dr. Adam Stern, a brave...
youtu.be
KCRS23 Meeting Insights: A Patient & Researcher Perspective with Dr. Adam Stern & Dr. Toni Choueiri
🔜Today!
Join an engaging conversation with @MoffittNews Cancer Center’s world-renowned GU Oncology Program.
· pioneering discoveries in research
· development of new clinical trials targeted at bladder & #kidneycancer
⏰6pm ET
Register: ...https://bit.ly/3RvrSxA
CC: @urotoday
Just in @JournalCancer 👉In a large multicenter prospective cohort of mRCC #kidneycancer active surveillance was pursued by >25% pts. 👇Congrats @MRHarrisonMD @Daniel_J_George https://t.co/XGvEgFztt5 Need biomarkers to characterize these pts @OncoAlert @urotoday
Latest News
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.
